IRIS Accounts Production v25.4.0.155 03848523 Board of Directors 1.4.24 31.3.25 31.3.25 0 0 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary D 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 03848523 2024-03-31 03848523 2025-03-31 03848523 2024-04-01 2025-03-31 03848523 2023-03-31 03848523 2023-04-01 2024-03-31 03848523 2024-03-31 03848523 ns15:EnglandWales 2024-04-01 2025-03-31 03848523 ns14:PoundSterling 2024-04-01 2025-03-31 03848523 ns10:Director1 2024-04-01 2025-03-31 03848523 ns10:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 03848523 ns10:SmallEntities 2024-04-01 2025-03-31 03848523 ns10:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 03848523 ns10:SmallCompaniesRegimeForDirectorsReport 2024-04-01 2025-03-31 03848523 ns10:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 03848523 ns10:AbridgedAccounts 2024-04-01 2025-03-31 03848523 ns10:OrdinaryShareClass2 2024-04-01 2025-03-31 03848523 ns10:OrdinaryShareClass3 2024-04-01 2025-03-31 03848523 ns10:OrdinaryShareClass4 2024-04-01 2025-03-31 03848523 ns10:OrdinaryShareClass5 2024-04-01 2025-03-31 03848523 ns10:Director2 2024-04-01 2025-03-31 03848523 ns10:Director3 2024-04-01 2025-03-31 03848523 ns10:Director4 2024-04-01 2025-03-31 03848523 ns10:RegisteredOffice 2024-04-01 2025-03-31 03848523 ns5:CurrentFinancialInstruments 2025-03-31 03848523 ns5:CurrentFinancialInstruments 2024-03-31 03848523 ns5:ShareCapital 2025-03-31 03848523 ns5:ShareCapital 2024-03-31 03848523 ns5:RetainedEarningsAccumulatedLosses 2025-03-31 03848523 ns5:RetainedEarningsAccumulatedLosses 2024-03-31 03848523 ns5:FurnitureFittings 2024-04-01 2025-03-31 03848523 ns5:MotorVehicles 2024-04-01 2025-03-31 03848523 ns5:DeferredTaxation 2024-03-31 03848523 ns5:DeferredTaxation 2025-03-31 03848523 ns10:OrdinaryShareClass2 2025-03-31 03848523 ns10:OrdinaryShareClass3 2025-03-31 03848523 ns10:OrdinaryShareClass4 2025-03-31 03848523 ns10:OrdinaryShareClass5 2025-03-31

REGISTERED NUMBER: 03848523 (England and Wales)

| FINANCIAL STATEMENTS |

| FOR THE YEAR ENDED 31ST MARCH 2025 |

| FOR |

| C D & J H MEDICAL LIMITED |

| C D & J H MEDICAL LIMITED (REGISTERED NUMBER: 03848523) |

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST MARCH 2025

Page |

| Company Information | 1 |

| Abridged Balance Sheet | 2 |

| Notes to the Financial Statements | 4 |

| C D & J H MEDICAL LIMITED |

COMPANY INFORMATION

FOR THE YEAR ENDED 31ST MARCH 2025

| DIRECTORS: | Dr C D Heath

| Mrs J Heath

| Mrs K J Heath

| Dr C J Heath

| REGISTERED OFFICE: | c/o Michael Heaven & Associates Limited

| 47 Calthorpe Road

| Edgbaston

| BIRMINGHAM

| West Midlands

| B15 1TH

| REGISTERED NUMBER: | 03848523 (England and Wales)

| ACCOUNTANTS: | Michael Heaven & Associates Limited

| Chartered Certified Accountants

| 47 Calthorpe Road

| Edgbaston

| BIRMINGHAM

| B15 1TH

| INCORPORATION: | 27th September 1999

| C D & J H MEDICAL LIMITED (REGISTERED NUMBER: 03848523) |

ABRIDGED BALANCE SHEET

31ST MARCH 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 16,505 |  | 20,631 |  |

Investments | 5 | 19,102 |  | 19,102 |  |

35,607 |  | 39,733 |  |

CURRENT ASSETS

Debtors | 31,794 |  | 23,363 |  |

Cash at bank | 98,165 |  | 93,657 |  |

129,959 |  | 117,020 |  |

CREDITORS

Amounts falling due within one year | 70,410 |  | 86,741 |  |

NET CURRENT ASSETS | 59,549 |  | 30,279 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 95,156 |  | 70,012 |  |

PROVISIONS FOR LIABILITIES | 6 | 4,374 |  | 5,467 |  |

NET ASSETS | 90,782 |  | 64,545 |  |

CAPITAL AND RESERVES

Called up share capital | 7 | 100 |  | 100 |  |

Retained earnings | 90,682 |  | 64,445 |  |

SHAREHOLDERS' FUNDS | 90,782 |  | 64,545 |  |

| C D & J H MEDICAL LIMITED (REGISTERED NUMBER: 03848523) |

ABRIDGED BALANCE SHEET - continued

31ST MARCH 2025

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31st March 2025 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21st November 2025 and were signed on its behalf by:

Dr C D Heath - Director

| C D & J H MEDICAL LIMITED (REGISTERED NUMBER: 03848523) |

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST MARCH 2025

1. | STATUTORY INFORMATION

| C D & J H Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover represents the value of services provided to the extent that there is a right to consideration and is recorded at the value of the consideration due.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Fixtures and fittings | - | 20% on reducing balance

| Motor vehicles | - | 20% on reducing balance

| Financial instruments

| The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, and loans from related parties.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| C D & J H MEDICAL LIMITED (REGISTERED NUMBER: 03848523) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31ST MARCH 2025

2. | ACCOUNTING POLICIES - continued

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Debtors

| Short term debtors are measured at transaction price, less any impairment.

| Creditors

| Short term trade creditors are measured at the transaction price.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was NIL (2024 - NIL).

4. | TANGIBLE FIXED ASSETS

| Totals

£ |

| COST

| At 1st April 2024

| and 31st March 2025 | 50,693 |  |

| DEPRECIATION

| At 1st April 2024 | 30,062 |  |

| Charge for year | 4,126 |  |

| At 31st March 2025 | 34,188 |  |

| NET BOOK VALUE

| At 31st March 2025 | 16,505 |  |

| At 31st March 2024 | 20,631 |  |

| C D & J H MEDICAL LIMITED (REGISTERED NUMBER: 03848523) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31ST MARCH 2025

5. | FIXED ASSET INVESTMENTS

| Information on investments other than loans is as follows:

| Totals

£ |

| COST

| At 1st April 2024

| and 31st March 2025 | 19,102 |  |

| NET BOOK VALUE

| At 31st March 2025 | 19,102 |  |

| At 31st March 2024 | 19,102 |  |

| The company owns shares in Bromsgrove Healthcare Innovations Limited. A reliable valuation for the shares at the balance sheet date is not available.

6. | PROVISIONS FOR LIABILITIES

2025 | 2024 |

£ | £ |

| Deferred tax | 4,374 |  | 5,467 |  |

| Deferred |

| tax |

£ |

| Balance at 1st April 2024 | 5,467 |  |

| Movement | (1,093 | ) |

| Balance at 31st March 2025 | 4,374 |  |

| Provisions are recognised when the company has a legal or constructive obligation at the reporting date as a result of a past event, it is probable that the company will be required to settle the obligation and the amount of the obligation can be reliably estimated.

| Provisions are recognised at the best estimate of the amount required to settle the obligation at the reporting date.

| C D & J H MEDICAL LIMITED (REGISTERED NUMBER: 03848523) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31ST MARCH 2025

7. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 2025 | 2024 |

| value: | £ | £ |

| 10 | Ordinary A | £1 | 10 |  | 10 |  |

| 34 | Ordinary B | £1 | 34 |  | 34 |  |

| 33 | Ordinary C | £1 | 33 |  | 33 |  |

| 23 | Ordinary D | £1 | 23 |  | 23 |  |

100 |  | 100 |  |

8. | RELATED PARTY DISCLOSURES

| As at the year end the amount due to the directors totalled £42,149 (2024- £64,107). The loans are interest free and repayable on demand.